Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

General Mills' (GIS) Q4 Earnings & Sales Top Estimates, Drop Y/Y

Published 06/30/2021, 03:33 AM
Updated 07/09/2023, 06:31 AM

General Mills (NYSE:GIS), Inc. GIS posted fourth-quarter fiscal 2021 results, wherein both top and bottom lines declined year over year but surpassed their respective Zacks Consensus Estimate. Results were affected by tough comparisons with the year-ago period’s initial pandemic-led demand surge and an additional week of results. However, recovery in away-from-home food demand remains an upside.

That said, management expects input cost inflation in fiscal 2022, while it remains focused on countering these challenges with its saving and pricing actions. Also, General Mills remains on track with its Accelerate strategy to aid growth. Though at-home food demand is likely to decline year over year, it is expected to remain higher than the pre-pandemic level, thanks to elevated cooking and baking at home. The company remains focused on capitalizing on these opportunities on the back of its strong brands, innovation and capacity to generate growth.

General Mills, Inc. Price, Consensus and EPS Surprise

General Mills, Inc. price-consensus-eps-surprise-chart | General Mills, Inc. Quote

Quarterly Highlights

The company’s adjusted earnings per share of 91 cents tumbled 19% year over year on a constant-currency (cc) basis. The year-over-year downside can be accountable to reduced adjusted operating profit. Nonetheless, the bottom line surpassed the Zacks Consensus Estimate of 83 cents.

Net sales of $4,523.6 million fell 10% year over year, which included a headwind of 5 points related to an additional week of results in the year-ago period, as well as a 2-point positive impact from currency movements. Organic net sales fell 6% due to reduced organic pound volume, which in turn was a result of tough comparisons with the year-ago period’s spike in the at-home food demand due to the coronavirus outbreak.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On a two-year compound growth basis (or compared to the pre-pandemic level), organic net sales rose 4%. The top line came ahead of the Zacks Consensus Estimate of $4,331 million.

Adjusted gross margin contracted 160 basis points (bps) to 34.5% due to adverse manufacturing leverage.

Adjusted operating profit fell 18% at cc to $740 million due to reduced adjusted gross profit dollars. These were somewhat offset by lower SG&A expenses. Adjusted operating profit margin contracted 140 bps to 16.3%.

Segmental Performance

North America Retail: Revenues in the segment came in at $2,640.1 million, down 17% year over year. The downside was due to comparisons with the year-ago period’s initial demand spike due to the pandemic, as well as a headwind of 6 points associated with an additional week in the year-ago period. Organic sales also fell 13% due to soft organic pound volume, somewhat made up by better organic net price realization and mix.

Convenience Stores & Foodservice: Revenues surged 25% to $493.2 million, thanks to better comparison with the year-ago period’s decline in away-from-home food demand owing to the pandemic. This was partly negated by headwinds related to an additional week in the same period last year. Organic sales jumped 33%.

Europe & Australia: The segment’s revenues rose 2% to $538.9 million, including favorable currency impacts of 10 points and an adverse impact of 6 points related to an additional week of results in the year-ago period. Sales fell 2% year over year on an organic basis due to tough comparisons with the demand surge in the year-ago period.

Asia & Latin America: Revenues rose 17% from the year-ago quarter’s figure to $407 million on elevated at-home food demand induced by the pandemic; a revival in away-from-home food outlets like Haagen-Dazs in Asia and positive currency movements. This was partly negated by headwinds related to an additional week of results in the year-ago period. Organic sales grew 22%.

Pet Segment: Revenues came in at $444.4 million, down 20% year over year due to tough comparisons with the year-ago period, which included results of an additional month as well as escalated pandemic-led stock up demand from pet parents.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Image Source: Zacks Investment Research

Other Financial Aspects

The company ended the quarter with cash and cash equivalents of $1,505.2 million, long-term debt of $9,786.9 million and total shareholders’ equity of $9,773.2 million. General Mills generated $2,983.2 million as net cash from operating activities in fiscal 2021. Capital investments amounted to $531 million in the fiscal.

Further, the company paid out dividends worth $1.25 billion and bought roughly 5 million shares for $301 million. On Jun 29, General Mills announced a dividend of 51 cents per share, which is payable on Aug 2, 2021, to shareholders of record as of Jul 9.

Other Developments & Outlook

Constant-currency sales from joint ventures of Cereal Partners Worldwide dipped 2% in the quarter. In Haagen-Dazs Japan, sales improved 12% at cc from the prior-year quarter’s figure.

In fiscal 2022, management expects at-home food demand to decrease on a year-over-year basis in most of the company’s core markets, while the same is likely to be greater than pre-pandemic levels. At the same time, the company expects continued recovery in away-from-home food demand, though it is not likely to fully reach pre-pandemic levels in fiscal 2022.

As nearly 85% of General Mills’ net sales reflect at-home food occasions, the abovementioned factors indicate reduced year-over-year aggregate consumer demand across categories in fiscal 2022.

Moving to costs, the company expects total input cost inflation to be around 7% of the cost of goods sold in fiscal 2022. However, management remains on track to counter the inflationary woes with its solid HMM cost savings, which are anticipated to be 4% of the cost of goods sold.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Also, favorable net price realization stemming from the company’s Strategic Revenue Management capacity is likely to aid in countering cost woes. As part of the Strategic Revenue Management, the company has already unveiled pricing actions in most parts of its portfolio.

All said, full-year organic net sales are expected to decrease 1-3% in fiscal 2022, due to soft consumer demand. Adjusted operating profit at cc is anticipated to fall 2-4% from $3.2 billion recorded in fiscal 2021. Adjusted earnings per share at cc is envisioned between flat and 2% down compared with $3.79 reported in fiscal 2021.

Compared to the fiscal 2019 pre-pandemic level, the midpoint of these guidance ranges indicates a three-year compound annual growth of about 2% each for organic net sales and adjusted operating profit (at cc), and 5% for adjusted EPS at cc.

This Zacks Rank #3 (Hold) stock has increased 3.9% year to date compared with the industry’s growth of 7.3%.

3 Stocks Worth Relishing

Medifast (NYSE:MED) MED, which currently carries a Zacks Rank #1 (Strong Buy), has a trailing four-quarter earnings surprise of 12.7%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.

Darling Ingredients (NYSE:DAR) DAR, with a Zacks Rank #1, has a trailing four-quarter earnings surprise of 29.8%, on average.

Nomad Foods (NYSE:NOMD) NOMD has a Zacks Rank #2 (Buy) and its bottom line outpaced the Zacks Consensus Estimate by 10.3% in the trailing four quarters, on average.

Bitcoin, Like the Internet Itself, Could Change Everything

Blockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the “Internet of Money” and predict it could change the way money works forever. If true, it could do to banks what Netflix (NASDAQ:NFLX) did to Blockbuster and Amazon (NASDAQ:AMZN) did to Sears. Experts agree we’re still in the early stages of this technology, and as it grows, it will create several investing opportunities.

Zacks’ has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

See 3 crypto-related stocks now >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

General Mills, Inc. (GIS): Free Stock Analysis Report

Darling Ingredients Inc. (DAR): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report

Nomad Foods Limited (NOMD): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.